{"id":"W1985683972","doi":"10.1016/j.ijrobp.2010.07.932","title":"RTOG 0417: A Phase II Study of Bevacizumab in Combination with Definitive Radiotherapy and Cisplatin Chemotherapy in Untreated Patients with Locally Advanced Cervical Carcinoma","year":2010,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Bevacizumab; Neutropenia; Adverse effect; Mucositis; Internal medicine; Chemoradiotherapy; Cervical cancer; Febrile neutropenia; Nedaplatin; Surgery; Radiation therapy; Phases of clinical research; Chemotherapy; Cisplatin; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001586225,0.001518423,0.003534595,0.0009093886,0.0005338745,0.001355312,0.001627148,0.001328508,0.005206292],"category_scores_gemma":[0.001247071,0.001001286,0.001756165,0.0008219782,0.001350463,0.001274702,0.0004732866,0.004366715,0.00124503],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00152721,"about_ca_system_score_gemma":0.003004696,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003355856,"about_ca_topic_score_gemma":0.009095611,"domain_scores_codex":[0.9994938,0.0002451429,0.00002385562,0.00008117778,0.00003766648,0.0001183062],"domain_scores_gemma":[0.9992919,0.0001443976,0.0001087507,0.00005619874,0.00003744243,0.0003613015],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6336231,0.08987018,0.008984799,0.001645639,0.003560498,0.0003181424,0.0007092854,0.00623451,0.03607874,0.0006973859,0.007565768,0.2107119],"study_design_scores_gemma":[0.5589681,0.4223415,0.008423302,0.00006545227,0.001055314,0.0002869,0.0001437263,0.001938258,0.003025318,0.0002259005,0.003473972,0.00005237315],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921191,0.003026764,0.0004184651,0.0005458908,0.0002033556,0.001406318,0.0006274622,0.0001413625,0.001511201],"genre_scores_gemma":[0.9850827,0.003785562,0.00241722,0.0007923673,0.0002497735,0.002294443,0.001936009,0.00008660687,0.003355213],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005206292,"threshold_uncertainty_score":0.01741678,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01147115946245053,"score_gpt":0.3153215164596936,"score_spread":0.3038503569972431,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}